Robotic bariatric surgery in Australia: early outcomes from a national clinical quality registry with propensity score matched analysis.

The robotic approach to metabolic bariatric surgery (MBS) is becoming more popular despite limited data supporting beneficial outcomes. The objective of this study was to evaluate the early outcomes of robotic MBS in Australia. An observational analysis of prospectively maintained data from the Australian arm of the Australia and New Zealand Bariatric Surgery Registry between 2014 to June 2022 were conducted. All patients who underwent robotic MBS (RMBS) were propensity score matched 1:1 to laparoscopic MBS (LMBS) within the Registry. Clinical outcomes were compared using conditional logistic regression analyses. A total of 66,232 patients were included (LMBS n = 65,322; RMBS n = 910) in the analysis. The majority of RMBS were gastric or duodenal-ileal bypasses, significantly higher than the LMBS cohort (49.6 vs 24.3%, p < 0.0001) and more were revisional procedures (26% vs 19.6%, p < 0.0001). On direct comparison, there were significantly more defined adverse events in the RMBS group. When adjusted for cofounders, clinical outcomes of RMBS were comparable to LMBS with no increased risks of defined adverse events or complications.